Iovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) was upgraded by TD Cowen to a “strong-buy” rating in a research note issued on Monday,Zacks.com reports. IOVA has been the topic of a number of other reports. Weiss Ratings restated a “sell (d-)” rating on shares of Iovance Biotherapeutics in a research note on Thursday, July 2nd. […]

Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA – Get Free Report) was upgraded by TD Cowen to a “strong-buy” rating in a research note issued on Monday,Zacks.com reports. Other research analysts have also recently issued reports about the stock. HC Wainwright restated a “buy” rating and issued a $45.00 price objective on shares of Damora Therapeutics, […]